Qinghai Spring Medicinal Resources Technology Co Ltd (600381.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE0000017W0

Price
3.87 CNY
Market cap
2.27 bn CNY
P/E (2025)
–
P/S (2025)
6.62
Dividend yield
0.00 %
Net margin
-10.87 %
Return on equity (ROE)
-3.75 %
Return on assets (ROA)
-3.57 %

Qinghai Spring Medicinal Resources Technology Co Ltd financials

Fiscal year20242025
Revenue270.26 m CNY343.42 m CNY
Gross profit66.77 m CNY142.41 m CNY
Operating income-194.95 m CNY1.07 m CNY
EBIT-200.24 m CNY-24.80 m CNY
Net income-198.77 m CNY-37.32 m CNY
Diluted EPS – continuing operations-0.34 CNY-0.06 CNY

Full history since 1998, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Qinghai Spring Medicinal Resources Technology Co Ltd

Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health and wellness products in China and internationally. It operates through three segments: Big Health Business, Beverage & Fast-Moving Consumer Goods, and Advertising Agency. The Big Health Business segment engages in the research, development, production, and sales of cordyceps sinensis products. The Beverage & Fast-Moving Consumer Goods segment is involved in the sale of beverages and other goods. The Advertising Agency segment provides advertising agency and publishing services. The company also actively explores new businesses to create new growth points and ensure sustainable development. Qinghai Spring Medicinal Resources Technology Co., Ltd. was founded in 1998 and is headquartered in Xining, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.